Jeito Capital
-
King of Prussia’s XyloCor Therapeutics Raises $67.5 Million to Advance Gene Therapy
King of Prussia-based XyloCor Therapeutics has managed to raise $67.5 million in Series B financing to advance its gene therapy…
Jeito Capital

King of Prussia-based XyloCor Therapeutics has managed to raise $67.5 million in Series B financing to advance its gene therapy…